Bold take: Starling Marte’s signing signals the Royals’ bold push to fortify their outfield with veteran excellence, depth, and a proven track record—despite the risks that come with a one-year deal. But here’s where it gets controversial: can a short-term upgrade truly shift a franchise’s trajectory, or will this just be a temporary spark?
Kansas City Royals announce a one-year Major League contract for outfielder Starling Marte, who will wear number 0. In the same move, the club designated outfielder Dairon Blanco for assignment.
Marte, 37, brings 14 MLB seasons of experience across several clubs—Pittsburgh (2012–19), Arizona (2020), Miami (2020–21), Oakland (2021), and the Mets (2022–25). He’s a career .285 hitter with a .781 OPS and stands among a select group: one of only 19 players in MLB history—and the sole active player—with at least 150 home runs and 350 stolen bases.
Among active players, Marte also leads in stolen bases (361), hit-by-pitches (166), and outfield assists (107). His 55 career triples are tied for the most among active players with Mike Trout.
Marte has earned All-Star selections with Pittsburgh in 2016 and with the Mets in 2022, and he captured Rawlings Gold Glove Awards in back-to-back seasons (2015–16) with Pittsburgh.
Postseason experience is substantial, with 25 games across six different seasons. His most recent postseason run came in 2024 with the Mets, where he hit .277 (13-for-47) with 9 RBI in 13 games.
Last season, Marte posted a .270 average (79-for-293) and a .745 OPS in 98 games for the Mets. He recorded starts at designated hitter (66), left field (6), and right field (2). After a slow start—hitting .220 (22-for-100) through his first 41 games—he heated up, batting .295 (57-for-193) over his final 57 games.
Implications for the Royals go beyond the numbers: Marte’s combination of speed, defensive reliability, and left-handed pop could complement Kansas City’s lineup and veteran leadership core. The one-year term provides a low-commitment opportunity to evaluate fit, while the team partakes in a potential midseason spark if Marte remains productive and healthy.
Questions for readers: Do you see Marte’s one-year deal as a meaningful catalyst for a playoff push, or is it a prudent roster depth move with limited upside? How would you balance the value of a veteran presence against the risk of age and potential injury in a spring season? Share your perspective in the comments.
